Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10216/153806Registo completo
| Campo DC | Valor | Idioma |
|---|---|---|
| dc.creator | Fernandes, AR | |
| dc.creator | Sanchez-Lopez, E | |
| dc.creator | Santini, A | |
| dc.creator | Santos, T | |
| dc.creator | Garcia, ML | |
| dc.creator | Silva, AM | |
| dc.creator | Souto, EB | |
| dc.date.accessioned | 2023-11-08T09:57:51Z | - |
| dc.date.available | 2023-11-08T09:57:51Z | - |
| dc.date.issued | 2021 | |
| dc.identifier.issn | 2079-4991 | |
| dc.identifier.uri | https://hdl.handle.net/10216/153806 | - |
| dc.description.abstract | Oil-in-water nanoemulsions (NEs) are considered a suitable nanotechnological approach to improve the eye-related bioavailability of lipophilic drugs. The potential of cationic NEs is prominent due to the electrostatic interaction that occurs between the positively charged droplets with the negatively charged mucins present in the tear film. This interaction offers prolonged NEs residence at the ocular surface, increasing the drug absorption. Triamcinolone acetonide (TA) is one of the first pharmacologic strategies applied as an intravitreal injection in the treatment of age-related macular degeneration (AMD). Newly synthesized quaternary derivatives of 1,4-diazabicyclo[2.2.2]octane (DABCO) and quinuclidine surfactants have been screened with the purpose to select the best compound to formulate long-term stable NEs that combine the best physicochemical properties for the loading of TA intended for ocular administration. | |
| dc.description.sponsorship | This work was funded by the Portuguese Science and Technology Foundation (FCT) from the Ministry of Science and Technology (MCTES), European Social Fund (FSE) of EU, for the scholarship SFRH/BD/130555/2017 granted to A. R. Fernandes, and for the projects UIDB/04469/2020 (CEB strategic fund) and UIDB/04033/2020 (CITAB), co-funded by European Funds (PRODER/COMPETE) and FEDER, under the Partnership Agreement PT2020. | |
| dc.language.iso | eng | |
| dc.publisher | MDPI | |
| dc.relation | info:eu-repo/grantAgreement/FCT/POR_NORTE/SFRH%2FBD%2F130555%2F2017/PT | |
| dc.relation | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04469%2F2020/PT | |
| dc.relation | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04033%2F2020/PT | |
| dc.relation.ispartof | Nanomaterials, vol.11(10):2758 | |
| dc.rights | openAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Cationic nanoemulsions | |
| dc.subject | DABCO surfactants | |
| dc.subject | Ocular administration | |
| dc.subject | Quinuclidine surfactants | |
| dc.subject | Triamcinolone acetonide | |
| dc.title | Mono- and Dicationic DABCO/Quinuclidine Composed Nanomaterials for the Loading of Steroidal Drug: 32 Factorial Design and Physicochemical Characterization | |
| dc.type | Artigo em Revista Científica Internacional | |
| dc.contributor.uporto | Instituto de Investigação e Inovação em Saúde | |
| dc.identifier.doi | 10.3390/nano11102758 | |
| dc.relation.publisherversion | https://www.mdpi.com/2079-4991/11/10/2758 | |
| Aparece nas coleções: | I3S - Artigo em Revista Científica Internacional | |
Ficheiros deste registo:
| Ficheiro | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| 10.3390-nano11102758.pdf | 7.65 MB | Adobe PDF | ![]() Ver/Abrir |
Este registo está protegido por Licença Creative Commons
